NCT05448924 is a clinical trial of Hormone panel tests in Growth Hormone Deficiency, sponsored by Universitas Padjadjaran.

Who is sponsoring NCT05448924?

NCT05448924 is sponsored by Universitas Padjadjaran.

What drugs are being tested in NCT05448924?

Interventions in NCT05448924: Hormone panel tests.

What condition does NCT05448924 study?

NCT05448924 studies Growth Hormone Deficiency.

Is NCT05448924 still recruiting?

NCT05448924 is currently completed. Last updated 8 July 2022.

Last reviewed 2022-07-08 · How we verify

NCT05448924

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Isolated Growth Hormone Deficiency and Amennorrhea

Completed Last updated 8 July 2022

What this trial tests

trial testing Hormone panel tests in Growth Hormone Deficiency in 1 participant. Completed in 31 January 2022.

Timeline

1 December 2021

Primary endpoint
1 January 2022

31 January 2022

Quick facts

Lead sponsor	Universitas Padjadjaran
Status	Completed
Study type	OBSERVATIONAL
Enrollment	1
Start date	1 December 2021
Primary completion	1 January 2022
Estimated completion	31 January 2022
Sites	1 location across Indonesia

Drugs / interventions tested

Hormone panel tests

Conditions studied

Growth Hormone Deficiency — all drugs for Growth Hormone Deficiency →

Sponsor

Universitas Padjadjaran — full company profile →

Who can join

Eligibility, female only, with Growth Hormone Deficiency. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a case report of a 14-year old female with no menstruation history.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Isolated growth hormone deficiency and amenorrhea - Case report.
Susilo AFP, Tjandraprawira KD, Rachmawati A. · · 2022 · cited 1× · PMID 36582894 · DOI 10.1016/j.amsu.2022.104909

Verify or expand the search:

Other recruiting trials for Growth Hormone Deficiency

Currently open trials in the same condition.

NCT06542809 — Evaluation of the Propensity of Patients Under rhGH to Envision a Modification of Their Treatment Regimen Toward LAGH · NA · recruiting
NCT05681299 — Effects of GH and Lirglutide on AgRP · Phase 4 · recruiting
NCT06455956 — Use of miRNAs in Growth Hormone Deficiency (GHD) · recruiting

Other Universitas Padjadjaran trials

Trials by the same sponsor.

NCT07506486 — Effect of Immersive Virtual Reality Cognitive Rehabilitation on Subacute Stroke Patients (A Pilot Study) · NA · not yet recruiting
NCT07494357 — Effects of Dual Task-Oriented Circuit Training on Walking Recovery in Sub-acute Stroke · NA · not yet recruiting
NCT07451899 — TB Type and Spirometry Result vs. Functional Capacity Based on 6MWT in People With Post-TB Lung Disease · not yet recruiting
NCT07467954 — Comparative Effectiveness of Long-Pulsed 1064-nm Nd:YAG and Fractional CO₂ Laser in Skin Rejuvenation · NA · recruiting
NCT07344688 — The Effect of White Tea in Healthy Human Subjects · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05448924 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Universitas Padjadjaran
Last refreshed: 8 July 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05448924.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing